References
- Hayes R , LeLacheurR, DumontIet al. 9th GCC Closed Forum: CAPA in regulated bioanalysis; method robustness, biosimilars, preclinical method validation, endogenous biomarkers, whole blood stability, regulatory audit experiences and electronic laboratory notebooks. Bioanalysis8 (6), 487–495 (2016).
- Lowes S , AckermannBL. AAPS and US FDA Crystal City VI workshop on bioanalytical method validation for biomarkers. Bioanalysis8 (3), 163–167 (2016).
- Takahiro Nakamura . 7th Japan Bioanalysis Forum symposium: regulated bioanalysis, to a new stage. Bioanalysis8 (20), 2097–2102 (2016).
- Lee V , LiuA, GroeberEet al. Boston Society’s 11th Annual Applied Pharmaceutical Analysis conference. Bioanalysis8 (4), 259–264 (2016).
- Timmerman P , BlechS, WhiteSet al. Best practices for metabolite quantification in drug development: updated recommendation from the European Bioanalysis Forum. Bioanalysis8 (12), 1297–1305 (2016).
- de Zwart M , LauseckerB, GlobigSet al. Co-medication and interference testing in bioanalysis: a European Bioanalysis Forum recommendation. Bioanalysis8 (19), 2065–2070 (2016).
- Yang E , WelinkJ, CapeSet al. 2016 White Paper on recent issues in bioanalysis: focus on biomarker assay validation (BAV) (Part 1 – small molecules, peptides and small molecule biomarkers by LCMS). Bioanalysis8 (22), 2363–2378 (2016).
- Ramagiri S , MooreI. Hybridizing LBA with LC–MS/MS: the new norm for biologics quantification. Bioanalysis8 (6), 483–486 (2016).
- Haidar SH , ScheibnerKA. Bioanalytical inspections: organizational changes and regulatory perspectives. Bioanalysis8 (10), 999–1002 (2016).
- Kellie JF , KehlerJR, SzapacsME. Application of high-resolution MS for development of peptide and large-molecule drug candidates. Bioanalysis8 (3), 169–177 (2016).
- Hammond TG , MoesS, YouhannaSet al. Development and characterization of a pseudo multiple reaction monitoring method for the quantification of human uromodulin in urine. Bioanalysis8 (12), 1279–1296 (2016).
- Ayoglu B , SchwenkJM, NilssonP. Antigen arrays for profiling autoantibody repertoires. Bioanalysis8 (10), 1105–1126 (2016).
- Botrè F , de la TorreX, MazzarinoM. Multianalyte LC–MS-based methods in doping control: what are the implications for doping athletes?Bioanalysis8 (11), 1129–1132 (2016).
- de Aquino Neto FR , SarderlaVF, MirottiL, PizzattiL. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016. Bioanalysis8 (17), 1753–1756 (2016).
- Microscale Bioanalysis. www.tandfonline.com/toc/bio/8/9.
- Immunoaffinity MS. www.tandfonline.com/toc/bio/8/15.
- HRMS in DMPK. www.tandfonline.com/toc/bio/8/16.
- Bioanalysis of Biomarkers – Part 1. www.tandfonline.com/toc/bio/8/22.
- Bioanalysis of Biomarkers – Part 2. www.tandfonline.com/toc/bio/8/23.
- Methods and Techniques for Metabolic Phenotyping. www.tandfonline.com/toc/bio/9/1.
- ScholarOne Mnauscripts™ – Bioanalysis. https://mc04.manuscriptcentral.com/fs-bio.
- Future Science – Enago. http://futurescience.enago.com/.
- Bioanalysis LinkedIn Group . www.linkedin.com/groups/2819540.
- Bioanalysis Twitter Page. https://twitter.com/fsgbio.
- Future Science – Kudos. www.tandfonline.com/page/kudos.
- Altmetrics. www.altmetric.com.
- Bioanalysis Zone. www.bioanalysis-zone.com.